首页> 外国专利> PRODUCTION OF RADIOIODINATED 1--G(B)-D-ARABINOFURANOSYL)-5(E)-(2-IODOVINYL)URACIL, AND USES THEREOF, AND RELATED ANALOGUES INCORPORATING ALTERNATIVE HALOGEN RADIONUCLIDES, THE GENERAL RADIOHALOGENATION PRECURSORS, 1-(2,3,5-TRI-O-ACETYL--G(B)-D-ARABINOFURANOSYL)-5(Z AND E)-(2-TRIMETHYLSILYLVINYL)URAC

PRODUCTION OF RADIOIODINATED 1--G(B)-D-ARABINOFURANOSYL)-5(E)-(2-IODOVINYL)URACIL, AND USES THEREOF, AND RELATED ANALOGUES INCORPORATING ALTERNATIVE HALOGEN RADIONUCLIDES, THE GENERAL RADIOHALOGENATION PRECURSORS, 1-(2,3,5-TRI-O-ACETYL--G(B)-D-ARABINOFURANOSYL)-5(Z AND E)-(2-TRIMETHYLSILYLVINYL)URAC

机译:放射性标记的1-G(B)-D-阿拉伯呋喃糖基)-5(E)-(2-碘乙烯基)尿嘧啶的生产及其用途,以及包含类似的替代卤代放射性核素,一般放射性卤代前体,1-(2)的相关类似物3,5-三-O-乙酰基-G(B)-D-阿拉伯呋喃糖基)-5(Z和E)-(2-三甲基甲硅烷基乙烯基)尿嘧啶

摘要

anti radioactive compounds containing 1 - (beta - d-arabino - furanosyl) (5) (e) - (2 - [i] - uracil iodovinyl), described below, "[i] ivarau, as prototype for the class of compounds known as 1 - beta - arabinofuranosyl) (5) (e) - (2 - [*] - uracil, halogu00e9novinyl) following [*] and the new xvarau, precursor thereof, 1 - (3)5 - tri - n - acetyl - beta - arabinofuranosyl) - 5 (z, e) - (2) - trimu00e9thylsilylvinyl) uracil, listed below by tmsvarau, processes for the preparation of these compounds and the use of these formulas in which "i" refers to a radionuclide iodine and "x" refers to any radionuclide. alogu00e9nu00e9 appropriate.the inclusion of the appropriate gamma or positron) transmitter, or other appropriate radioncuclide "within the framework of [i] - ivarau makes this agent useful as a diagnostic tool for the detection of in vitro and in vivo infections due to herpes simplex virus.the inclusion of alpha emitting isotopes of iodine apropriu00e9s and / or beta / gamma, and / or associated with a decrease of auger electron (specifically nuclear toxic halogenated products, or other suitable structure of the agent, the agent is useful as a tool for single radiotherapeutic infections due to herpes simplex virus.for specific targeting of the lethal effects of radiation and / or alpha beta and / or auger electron decay effects at the site of the viral infection.
机译:含有1-(β-d-阿拉伯-呋喃糖基)(5)(e)-(2-[i]-尿嘧啶碘乙烯基)的抗放射性化合物,如下所述,“ [i] ivarau,作为化合物类别的原型[*]和新的xvarau及其前体1-(3)5-tri-n被称为1-β-阿拉伯呋喃糖基)(5)(e)-(2-[*]-尿嘧啶,halog u00e9novinyl) -乙酰基-β-阿拉伯呋喃糖基)-5(z,e)-(2)-Trimvarau在下面列出的Trim u00e9thylsilylvinylvinyl)尿嘧啶,这些化合物的制备方法以及其中“ i”的这些式的使用表示放射性核素碘,“ x”表示任何放射性核素。在[i]框架内包含适当的gamma或正电子发射器,或其他适当的放射性核素“ i”-ivarau该试剂可用作检测由单纯疱疹病毒引起的体外和体内感染的诊断工具。包括碘化丙酸和/或β的α发射同位素。 γ和/或与螺旋钻电子的减少有关(特别是核毒性卤化产物或其他合适的药物结构),该药物可用作单纯疱疹病毒引起的单一放射治疗感染的工具。在病毒感染部位辐射的致死作用和/或αβ和/或螺旋钻电子衰变作用。

著录项

相似文献

  • 专利
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号